SEP 11, 2026 · JOURNAL ARTICLE
Current evidence on the diagnosis and management of immune checkpoint inhibitor associated myocarditis
Discover Medicine
A narrative review synthesizing observational evidence and consensus diagnostic/management criteria from cardio-oncology societies to inform structured multidisciplinary care of a rare life-threatening adverse event.
Reported
Mortality (earlier cohorts)27 to 50%
Mortality (recent pooled estimate)approximately 26%
Incidence (monotherapy)approximately 1%